ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,064.07
1.42%
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs Yen
153.691
-1.30%
Brent Oil
83.61
0.08%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Protagonist Therapeutics Inc (PTGX)

  7. Protagonist Therapeutics Inc (PTGX) ニュース

PTGX Protagonist Therapeutics Inc

25.54
-0.02 (-0.08%)
取引時間後
最終更新日： 05:17:27
15分遅延
名称 銘柄コード 市場 種別
Protagonist Therapeutics Inc PTGX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.02 -0.08% 25.54 05:17:27
始値 安値 高値 終値 前日終値
25.74 25.28 26.21 25.54 25.56
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1622:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
2024/3/0210:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0210:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0210:27EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0206:32EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0107:48EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2910:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:12EDGAR2Form 8-K - Current report
2024/2/1421:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1421:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0106:05EDGAR2Form 8-K - Current report
2024/1/1910:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1910:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1622:01EDGAR2Form 8-K - Current report
2024/1/1210:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1007:25EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0822:00EDGAR2Form 8-K - Current report
2024/1/0510:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1906:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/0306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:40EDGAR2Form 8-K - Current report
2023/10/3105:30EDGAR2Form 8-K - Current report
2023/10/2405:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1205:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/0405:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:13EDGAR2Form 8-K - Current report
2023/7/0521:00EDGAR2Form 8-K - Current report
2023/7/0405:06EDGAR2Form 8-K - Current report
2023/5/1220:00PRNUSProtagonist Reports Positive Results from Phase 1 and..
2023/5/1205:05PRNUSProtagonist Therapeutics to Participate in the JMP..
2023/5/1123:17PRNUSProtagonist Therapeutics Announces Presentations at the 2023..
2023/5/0505:05PRNUSProtagonist Reports First Quarter 2023 Financial Results and..

最近閲覧した銘柄

NASDAQ
PTGX
Protagonist Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有